Profile data is unavailable for this security.
About the company
Chongqing Genrix Biopharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of antibody drugs. The Company’s products mainly include monoclonal antibody drugs and bispecific antibody drugs under research. In terms of source innovation, the Company has established a new phage-based presented two technical platforms, the monoclonal antibody drug discovery technology platform and the bispecific antibody drug discovery technology platform and established an efficient recombinant antibody drug process development platform in the drug development process.
- Revenue in CNY (TTM)1.12m
- Net income in CNY-764.12m
- Incorporated2015
- Employees547.00
- LocationChongqing Genrix Biopharmaceutical Co LtdCHONGQING 401338ChinaCHN
- Phone+86 2 361758666
- Fax+86 2 361758011
- Websitehttp://www.genrixbio.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co | 2.93bn | 810.63m | 10.45bn | 601.00 | 11.55 | 2.20 | -- | 3.56 | 2.81 | 2.81 | 9.65 | 14.76 | 0.6016 | 1.81 | 6.68 | 4,877,892.00 | 16.83 | 12.44 | 23.18 | 15.71 | 93.68 | 90.51 | 27.97 | 20.43 | 2.79 | 7.96 | 0.1716 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.43bn | 523.43m | 10.74bn | 8.41k | 20.69 | 1.50 | -- | 1.67 | 0.202 | 0.202 | 2.49 | 2.78 | 0.5568 | 2.39 | 4.60 | 764,058.90 | 5.02 | 6.77 | 7.25 | 10.50 | 54.36 | 63.24 | 9.02 | 11.10 | 1.53 | 40.71 | 0.1459 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.07bn | 352.22m | 11.34bn | 965.00 | 32.19 | 2.27 | -- | 10.56 | 0.571 | 0.571 | 1.74 | 8.09 | 0.2078 | 1.14 | 9.25 | 1,112,527.00 | 6.61 | 1.32 | 6.93 | 1.41 | 77.85 | 80.74 | 31.81 | 6.55 | 6.66 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 3.26bn | 453.31m | 11.39bn | 2.88k | 25.13 | 2.91 | -- | 3.50 | 1.05 | 1.05 | 7.56 | 9.08 | 0.6482 | 5.87 | 11.13 | 1,130,851.00 | 9.26 | 10.82 | 11.03 | 13.47 | 42.87 | 41.18 | 14.29 | 14.08 | 5.18 | -- | 0.0729 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Chongqing Genrix Biophrmctcl Co Ltd | 1.12m | -764.12m | 11.49bn | 547.00 | -- | 4.32 | -- | 10,280.50 | -2.08 | -2.08 | 0.0031 | 7.25 | 0.0005 | 0.0231 | 19.76 | 2,043.55 | -35.10 | -- | -37.12 | -- | -17.40 | -- | -68,358.07 | -- | 23.66 | -493.94 | 0.1946 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 1.80bn | 514.80m | 11.69bn | 2.47k | 22.71 | 2.68 | -- | 6.50 | 1.18 | 1.18 | 4.11 | 9.95 | 0.36 | 2.68 | 6.66 | 727,792.60 | 10.31 | -- | 11.11 | -- | 39.78 | -- | 28.63 | -- | 5.51 | -- | 0.0551 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| Changchun BCHT Biotechnology Co | 1.92bn | 543.19m | 11.70bn | 1.24k | 21.50 | 2.86 | -- | 6.11 | 1.32 | 1.32 | 4.64 | 9.88 | 0.4116 | 0.8459 | 1.55 | 1,543,550.00 | 11.67 | 9.95 | 14.14 | 12.81 | 89.90 | 86.63 | 28.36 | 24.03 | 2.03 | -- | 0.0158 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.43bn | 614.24m | 12.00bn | 2.53k | 19.40 | 4.06 | -- | 3.50 | 1.09 | 1.09 | 6.09 | 5.21 | 0.7246 | 2.04 | 13.84 | 1,356,471.00 | 12.97 | 10.68 | 21.27 | 16.56 | 71.74 | 74.42 | 17.90 | 14.92 | 1.26 | -- | 0.0122 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.25bn | 989.32m | 12.06bn | 4.88k | 12.16 | 1.38 | -- | 2.30 | 1.10 | 1.10 | 5.84 | 9.69 | 0.4523 | 1.87 | 4.36 | 1,076,055.00 | 8.52 | 10.10 | 11.07 | 13.69 | 35.80 | 34.64 | 18.83 | 16.26 | 2.07 | -- | 0.1816 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
| KPC Pharmaceuticals Inc | 7.65bn | 432.35m | 12.12bn | 5.05k | 27.97 | 2.24 | -- | 1.59 | 0.5725 | 0.5725 | 10.15 | 7.15 | 0.8021 | 2.48 | 2.62 | 1,513,702.00 | 4.63 | 5.42 | 7.76 | 9.13 | 43.12 | 43.68 | 5.77 | 5.70 | 1.46 | 53.93 | 0.1688 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Zhejiang Medicine Co., Ltd. | 8.04bn | 425.74m | 12.25bn | 6.23k | 28.50 | 1.26 | -- | 1.52 | 0.447 | 0.447 | 8.41 | 10.13 | 0.6329 | 2.91 | 5.57 | 1,290,409.00 | 2.14 | 4.32 | 2.75 | 5.68 | 31.16 | 36.57 | 3.39 | 6.28 | 1.62 | 5.95 | 0.0819 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| BrightGene Bio-Medical Technology Co Ltd | 1.21bn | 195.77m | 12.45bn | 1.16k | 64.50 | 5.13 | -- | 10.25 | 0.4569 | 0.4569 | 2.87 | 5.75 | 0.2463 | 1.69 | 4.43 | 1,051,700.00 | 3.43 | 6.53 | 4.29 | 7.93 | 54.92 | 56.93 | 13.93 | 19.90 | 1.45 | 4.86 | 0.4787 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 12.54bn | 3.36k | 630.77 | 0.4301 | -- | 1.12 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
Data as of Jul 26 2024. Currency figures normalised to Chongqing Genrix Biopharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
41.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 13.27m | 14.91% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 4.11m | 4.62% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.96m | 4.44% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 3.38m | 3.79% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 2.76m | 3.10% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 2.73m | 3.07% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 2.67m | 2.99% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.90m | 2.13% |
| Essence Fund Co., Ltd.as of 31 Dec 2023 | 1.41m | 1.58% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023 | 1.20m | 1.34% |
More ▼
Data from 31 Dec 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.
